A new era for combatting infectious diseases.
We are a biotechnology company developing monoclonal antibodies to revolutionize the treatment of infectious diseases. We target diseases that impact people all around the world and cause hundreds of billions in economic burden annually.
OUR MISSION IS TO AMELIORATE SUFFERING FROM INFECTIOUS DISEASES
Monoclonal antibodies (mAbs) developed in our laboratory can be used for the treatment and prevention of infectious diseases and represent a powerful strategy for combating global and local epidemics.
MABLOC has developed several mAbs (with its partners) that can be used for the treatment and prevention of infectious diseases including yellow fever, dengue, Zika, and COVID-19. See our pipeline page for progress on existing projects as well as our new and exciting ventures.